At A Glance
As COVID-19 rages across America, hospitals and health systems and their extraordinary staffs continue to bring care and comfort to our communities.
COVID-19 Special Bulletins
Below are links to AHA special bulletins developed in response to novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
The AHA will host two important calls for hospital and health system leaders on issues related to the COVID-19 pandemic.
In an open letter to the American public, the AHA, along with the Am
The Centers for Medicare & Medicaid Services (CMS) Nov.
The Department of Health and Human Services (HHS) today issued two important
The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
With the COVID-19 pandemic reaching the point in which vaccines against the coronavirus may soon be publicly available, the AHA is helping hospitals and health systems prepare for their arrival, while promoting public confidence in Food and Drug Administration-approved SARS-CoV-2 vaccines.
The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the treatment, the drug’s storage requirements and a brief overview of how distribution will work.
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, Operation
The Department of Health and Human Services issued an important clarification to its Oct. 22 reporting requirements for providers that received Provider Relief Fund payments.
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, providers should begin planning for the distribution and administration process of these therapeutics.
This Special Bulletin details the Office of the National Coordinator (ONC) for Health Information Technology’s interim final rule with comment period to delay the Nov. 2 compliance date for the information blocking provisions of ONC’s Cures Act final rule, while also extending timelines for certain requirements related to the certification of health IT.
The Department of Health and Human Services (HHS) Oct. 22 issued a revision to its reporting requirements for providers that received Provider Relief Fund (PRF) payments.
Other Events This Week Include HHS Webinars on COVID-19 Data Reporting and AHA
The Centers for Medicare & Medicaid Services (CMS) Oct. 8 announced new repayment terms for payments received under its Accelerated and Advance Payment (AAP) programs.
The Centers for Medicare & Medicaid Services (CMS) today released guidance on how it will implement an Aug. 25 interim final rule that makes collecting and reporting COVID-19 data a condition of participation (CoP) for hospitals that participate in Medicare.